ALKERMES | ALKS - L'Utile Operativo

Prezzo Delle Azioni
33.70
Cambio Giornaliero
-0.01 -0.03%
Mensile
-4.69%
Annuale
10.20%
Q2 Previsione
32.32




L'Utile Operativo Cambiamento Data
AbbVie USD 4.73B 1.08B 2026-03
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
ALKERMES USD -10.95M 100.03M 2025-12
Amgen USD 3.83B 130M 2026-03
Biogen USD 514.3M 128.8M 2026-03
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Gilead Sciences USD 2.96B 551M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Ionis Pharmaceuticals USD -118M 97M 2026-03
J&J USD 6.62B 1.03B 2026-03
Malin Corporation EUR -1.1M 400K 2024-12
Merck USD -1.88B 8.12B 2026-03
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Otsuka Holdings JPY 118.21B 50.97B 2026-03
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pfizer USD 4.65B 3.99B 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12